Imbalance between drug and non-drug reward availability: A major risk factor for addiction

被引:65
|
作者
Ahmed, SH [1 ]
机构
[1] Univ Victor Segalen Bordeaux 2, CNRS, UMR 5541, Lab Neuropsychobiol Desadaptat, F-33076 Bordeaux, France
关键词
addiction; dependence; behavioral economics; choice; dopamine; lateral hypothalamus; cocaine; heroin; prefrontal cortex;
D O I
10.1016/j.ejphar.2005.09.036
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Laboratory animals self-administer most, though not all, drugs of abuse. Recent evidence shows that with increased drug availability, most laboratory rats develop all the major behavioral signs of addiction, including: 1) drug intake escalation, 2) increased motivation for the drug, 3) difficulty to abstain, 4) decreased reward function, and 5) inflexible drug use. The large prevalence of addicted rats may suggest that they are particularly vulnerable to develop compulsive drug use. I review evidence showing that this apparent vulnerability results in large part from the lack of positive (i.e., alternative non-drug rewards) and negative (i.e., costs) incentives capable of turning animals away from the pursuit of drugs. In particular, most animals seem to take drugs and eventually become addicted, not because drugs are intrinsically addictive, but more likely because drugs are the only significant sources of reward available in the laboratory. Laboratory animals would therefore represent more of a model of high-risk human groups than of the general population. Consequently, they should be more suited for searching factors that protect from, rather than predispose to, drug addiction. Reconsidering the environmental background of drug self-administration experiments in laboratory animals raises intriguing implications for understanding the initial demand for drug consumption and the transition to drug addiction, and for extrapolation from laboratory animals to humans. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:9 / 20
页数:12
相关论文
共 50 条
  • [1] Dopamine, urges to smoke, and the relative salience of drug versus non-drug reward
    Freeman, Tom P.
    Das, Ravi K.
    Kamboj, Sunjeev K.
    Curran, H. Valerie
    SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE, 2015, 10 (01) : 85 - 92
  • [2] Glutamatergic transmission in drug reward: implications for drug addiction
    D'Souza, Manoranjan S.
    FRONTIERS IN NEUROSCIENCE, 2015, 9
  • [3] Reinstatement in a cocaine versus food choice situation: reversal of preference between drug and non-drug rewards
    Tunstall, Brendan J.
    Kearns, David N.
    ADDICTION BIOLOGY, 2014, 19 (05): : 838 - 848
  • [4] An Endocannabinoid Hypothesis of Drug Reward and Drug Addiction
    Onaivi, Emmanuel S.
    DRUG ADDICTION: RESEARCH FRONTIERS AND TREATMENT ADVANCES, 2008, 1139 : 412 - 421
  • [5] Quantifying value-based determinants of drug and non-drug decision dynamics
    Smith, Aaron P.
    Beckmann, Joshua S.
    PSYCHOPHARMACOLOGY, 2021, 238 (08) : 2047 - 2057
  • [6] Contextual and psychosocial factors influencing drug reward in humans: The importance of non-drug reinforcement
    Acuff, Samuel F.
    Oddo, Lauren E.
    Johansen, Alexandra N.
    Strickland, Justin C.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2024, 241
  • [7] Neurobiologic processes in drug reward and addiction
    Adinoff, B
    HARVARD REVIEW OF PSYCHIATRY, 2004, 12 (06) : 305 - 320
  • [8] Drug versus non-drug behaviors: A dual-reward model of sex differences and neurobiological mechanisms in rats
    Nall, Rusty W.
    Chalhoub, Reda M.
    Kalivas, Peter W.
    JOURNAL OF THE EXPERIMENTAL ANALYSIS OF BEHAVIOR, 2022, 117 (03) : 457 - 471
  • [9] Essential values of cocaine and non-drug alternatives predict the choice between them
    Kearns, David N.
    Kim, Jung S.
    Tunstall, Brendan J.
    Silberberg, Alan
    ADDICTION BIOLOGY, 2017, 22 (06) : 1501 - 1514
  • [10] The effects of nicotine dependence and acute abstinence on the processing of drug and non-drug rewards
    Lawn, W.
    Freeman, T. P.
    Hindocha, C.
    Mokrysz, C.
    Das, R. K.
    Morgan, C. J. A.
    Curran, H. V.
    PSYCHOPHARMACOLOGY, 2015, 232 (14) : 2503 - 2517